| Closed |
S1827 |
MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK) |
1/10/2020 |
12/15/2025 |
46% |
|
|
| Closed |
SWOG-7924 |
Multimodal Therapy for Limited Small Cell Carcinoma of the Lung |
11/2/1979 |
10/29/1982 |
|
|
Published
|
| Closed |
SWOG-8313 (EST 5186) |
Multiple Drug Adjuvant Chemotherapy for Patients with ER Negative Stage II Carcinoma of Breast |
4/20/1984 |
6/15/1990 |
100% |
|
Published
|
| Closed |
S1011 |
Muscle-Invasive Bladder Ca, Std vs Ext PLND, Ph III |
8/1/2011 |
4/15/2017 |
100% |
|
|
| Closed |
S0309 |
Myeloma Repository |
11/15/2003 |
|
|
|
|
| Open |
MYELOMATCH |
myeloMATCH MSRP |
5/16/2024 |
|
|
|
|
| Closed |
S1934 |
NASSIST |
9/9/2021 |
3/1/2023 |
0% |
|
|
| Closed |
SWOG-8923 |
Neo-FAC for Poor Prognosis St.IV Breast Cancer |
2/15/1990 |
6/1/1992 |
60% |
|
Published
|
| Closed |
SWOG-8805 |
Neoadjuvant Cisplatin and VP-16 Plus Concurrent Chest and Optional Brain Irradiation for Patients with Stage lll Non-Small Cell Lung Carcinoma |
7/1/1988 |
3/15/1992 |
100% |
|
Published
|
| Closed |
S1619 |
Neoadjuvant Cisplatin-Pemetrexed with Atezolizumab |
11/3/2017 |
5/1/2020 |
100% |
|
|
| Closed |
SWOG-8704 |
Neoadjuvant Methotrexate, Cisplatin and Vinblastine (MCV) Followed by Concomitant Cisplatin/Radiotherapy for Unresectable Localized Bladder Cancer Patients |
9/1/1987 |
8/15/1991 |
90% |
|
Published
|
| Closed |
S0012 |
NEOADJUVANT: Standard AC vs. Weekly A and Daily Oral C + G-CSF |
5/1/2001 |
12/1/2005 |
100% |
|
Published
|
| Closed |
S0925 |
New Hormone-Sensitive Metastatic PCa, Androgen Deprivation +/- IMC-A12, Ph II |
12/15/2010 |
12/1/2012 |
100% |
|
Published
|
| Closed |
S0204 |
Newly Diagnosed Multiple Myeloma Tandem Transplant |
6/15/2002 |
10/15/2005 |
100% |
|
Published
|
| Closed |
SWOG-7204/7205 |
Non-Hodgkin's Lymphoma CHOP vs. HOP Combination Chemotherapy for Remission Induction and COP vs. OAP Combination Chemotherapy for Maintenance |
4/17/1972 |
9/10/1974 |
|
|
Published
|
| Closed |
SWOG-7433 |
Non-Hodgkin's Lymphomas (Stages I, IE, II, and IIE) |
12/27/1974 |
1/29/1981 |
|
|
Published
|
| Closed |
S0108 |
NON-HODGKIN'S: Bevacizumab For Relapsed Aggressive NHL |
4/15/2001 |
12/1/2004 |
87% |
|
Published
|
| Closed |
S0313 |
NON-HODGKIN'S: CHOP + IF RT followed by Yttrium-90 Ibritumomab Tiuxetan |
2/1/2004 |
12/15/2008 |
77% |
|
Published
|
| Closed |
S0349 |
NON-HODGKIN'S: CHOP plus G3139 for Adv Stage Large B-cell of Low and Low-Int IPI Risk |
3/1/2004 |
5/15/2006 |
10% |
|
|
| Closed |
S0014 |
NON-HODGKIN'S: CHOP with concurrent rituximab plus IFR |
4/1/2000 |
1/15/2002 |
100% |
|
Published
|
